CIK 0000818686
- Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 39148213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,242,786
- in 10 filings, $10.6M under 10b5-1 plans
Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-09-18 | O'Grady Brendan P. EVP, North America Commercial | Sale | −494 | $7.83 | $4K | 2,135.49 |
| 2019-09-18 | O'Grady Brendan P. EVP, North America Commercial | Option exercise · Restricted Share Units | −1,241 | 0 | ||
| 2019-09-18 | Nazzi Gianfranco EVP, Growth Markets Commercial | Option exercise | +2,638 | 11,640.36 | ||
| 2019-09-18 | Nazzi Gianfranco EVP, Growth Markets Commercial | Sale | −962 | $7.82 | $8K | 10,678.36 |
| 2019-09-18 | Nazzi Gianfranco EVP, Growth Markets Commercial | Option exercise · Restricted Share Units | −2,638 | 0 | ||
| 2019-09-18 | McClellan Michael James EVP, Chief Financial Officer | Option exercise | +4,091 | 16,851.27 | ||
| 2019-09-18 | McClellan Michael James EVP, Chief Financial Officer | Sale | −1,406 | $7.83 | $11K | 15,445.27 |
| 2019-09-18 | McClellan Michael James EVP, Chief Financial Officer | Option exercise · Restricted Share Units | −4,091 | 0 | ||
| 2019-09-18 | Griffin Deborah A Chief Accounting Officer | Option exercise | +2,376 | 2,376 | ||
| 2019-09-18 | Griffin Deborah A Chief Accounting Officer | Sale | −2,376 | $7.83 | $19K | 0 |
| 2019-09-18 | Griffin Deborah A Chief Accounting Officer | Option exercise · Restricted Share Units | −2,376 | 0 | ||
| 2019-09-18 | Dethlefs Sven EVP Global Marketing&Portfolio | Option exercise | +1,446 | 10,594.7 | ||
| 2019-09-18 | Dethlefs Sven EVP Global Marketing&Portfolio | Option exercise · Restricted Share Units | −1,446 | 0 | ||
| 2019-09-18 | Daniell Richard Exec. VP, European Commercial | Option exercise | +2,489 | 2,852 | ||
| 2019-09-18 | Daniell Richard Exec. VP, European Commercial | Sale | −1,176 | $7.82 | $9K | 1,676 |
| 2019-09-18 | Daniell Richard Exec. VP, European Commercial | Option exercise · Restricted Share Units | −2,489 | 0 | ||
| 2019-09-09 | Daniell Richard Exec. VP, European Commercial | Option exercise | +696 | 696 | ||
| 2019-09-09 | Daniell Richard Exec. VP, European Commercial | Sale | −333 | $7.16 | $2K | 363 |
| 2019-09-09 | Daniell Richard Exec. VP, European Commercial | Option exercise · Restricted Share Units | −696 | 698 | ||
| 2019-06-11 | Nisen Perry Director | Grant or award · Restricted Share Units | +17,621 | 17,621 |
Page 62 of 76 · 1,517 trades